High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

Backgroud COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 202...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2021-02, Vol.51 (2), p.308-312
Hauptverfasser:	Ibañez, C., Perdomo, J., Calvo, A., Ferrando, C., Reverter, J. C., Tassies, D., Blasi, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - administration & dosage Cardiology Coronaviruses COVID-19 COVID-19 - blood COVID-19 Drug Treatment Disseminated intravascular coagulation Female Fibrin Fibrin Fibrinogen Degradation Products - metabolism Fibrinogen Fibrinolysis Hematology Humans Laboratories Lysis Male Medicine Medicine & Public Health Middle Aged Morbidity Mortality Prophylaxis Retrospective Studies Risk factors SARS-CoV-2 - metabolism Sepsis Septic shock Thrombelastography Thromboembolism Thromboembolism - blood Thromboembolism - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!